Company: SXTPW
Filing Date: 2025-02-06
Form Type: 424B5
Source: 0001213900-25-010772
Chunk: 37

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 424B5
Chunk 37
---
 4,395,505 shares issued and outstanding, pro forma; 7,364,554 shares issued and outstanding, pro forma as adjusted |     | $      |         186 |   |     | $            |         439 |   |     |                |         736 |   |
| Additional paid-in capital                                                                                                                                                                                                                                              |     | $      |  34,815,642 |   |     | $            |  34,921,386 |   |     |                |  36,844,856 |   |
| Accumulated other comprehensive income                                                                                                                                                                                                                                  |     | $      |     139,207 |   |     | $            |     139,207 |   |     |                |     139,207 |   |
| Accumulated deficit                                                                                                                                                                                                                                                     |     | $      | (38,482,920 | ) |     | $            | (38,482,920 | ) |     |                | (38,482,920 | ) |
| Total stockholders’ equity                                                                                                                                                                                                                                              |     | $      |   5,962,847 |   |     | $            |   6,068,844 |   |     |                |   7,992,567 |   |
| Total capitalization                                                                                                                                                                                                                                                    |     | $      |   7,420,893 |   |     | $            |   7,423,348 |   |     |                |   9,347,071 |   |

| (1) | Does                       
 not include the following: |

| ● | 285,373                                                           
 shares of common stock reserved for issuance under the 2022 Plan; |

| ● | 688,165                                                                                                                            
 shares of common stock issuable upon exercise of outstanding stock options at a weighted average exercise price of $2.78 per share |

| ● | 846,438                                                                                                                         
 shares of common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $26.01 per share; |

| ● | 444,000                                                                                          
 shares of common stock issuable upon the exercise of outstanding Pre-Funded Warrants to purchase 
 common stock at an exercise price of $0.001 per share;                                           |

| ● | 2,898,551                                                                                     
 shares of common stock issuable upon exercise of outstanding Series A warrants at an exercise 
 price of $1.38 per share;                                                                     |

| ●